lomerizine has been researched along with cysteine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoyagi, J; Ebina, J; Hanashiro, S; Ikeda, K; Ishikawa, Y; Iwasaki, Y; Kawabe, K; Kyuzen, M; Miura, K; Morioka, H; Murata, K; Nagasawa, J; Sawada, M; Takazawa, T; Yanagihashi, M | 1 |
Kuriyama, M; Mizuno, T; Mizuta, I; Shiga, Y; Shimoe, Y; Tachiyama, K | 1 |
2 other study(ies) available for lomerizine and cysteine
Article | Year |
---|---|
Preventive Treatment with Lomerizine Increases Cerebral Blood Flows during the Interictal Phase of Migraine.
Topics: Adult; Aged; Blood Flow Velocity; Calcium Channel Blockers; Cerebrovascular Circulation; Cysteine; Female; Humans; Male; Middle Aged; Migraine with Aura; Migraine without Aura; Organotechnetium Compounds; Perfusion Imaging; Piperazines; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2018 |
[CADASIL with cysteine-sparing NOTCH3 mutation manifesting as dissociated progression between cognitive impairment and brain image findings in 3 years: A case report].
Topics: Atrophy; Brain; CADASIL; Cerebrovascular Circulation; Cognition; Cognitive Dysfunction; Cysteine; Disease Progression; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Piperazines; Receptor, Notch3; Time Factors | 2018 |